Project Summary
For the first phase of our CoBRE award, we are aiming to develop infrastructure and expertise base, as
well as to build a critical mass of funded investigators for translational auditory and vestibular research.
Towards these goals, three groups led by Drs. Litao Tao, Justine Renauld, and Jun Xia respectively, will
collaborate to conduct a preliminary study of Ménière’s Disease, one debilitating disease affecting millions of
people.
Ménière’s Disease (MD), characterized by fluctuating hearing loss and vertigo, is a poorly understood
disease for which the etiology is still unknown. While the pathophysiology of MD remains to be discovered, it is
believed that this disorder arises from endolymph homeostasis imbalance. Endolymphatic hydrops, an
enlargement of the membranous labyrinth in the inner ear, is a hallmark of the disease. To gain better
understanding of this complex disease, this collaborative effort aims to look at 3 synergic ways to uncover the
development of MD and endolymphatic hydrops. In this project, we will (1) Identify and validate genetic
variants associated with MD from the whole genome sequencing data of more than 1300 patients suffering
from MD; (2) characterize the transcriptional changes of an endolymphatic hydrops mouse model’s lateral wall,
which is essential for endolymph production and regulation; and (3) identify the distal enhancers by epigenetic
study to correlate potential non-coding hot spots from the genetic variant highlighted in Aim 1 with the
functional genes affected in the lateral wall discovered in Aim 2. We believe this project with multiple
approaches will not only provide new insight into the pathogenesis of MD, but also improve our understanding
of lateral wall function and regulation which will have a significant impact for the development of future targeted
treatments for MD therapy but also other strial disorders.
This supplemental award project aligns with the goal of our CoBRE award. Through collaborations,
three teams can learn from each other and will gain new expertise together for studies of strial functions and
disorders. Results from this preliminary study will lay the foundation to further investigate the molecular
mechanisms of MD and to explore potential treatment options. As junior faculties, Drs. Tao, Renauld and Xia
will seek funding through NIH or private foundations to support their future studies on MD.
Public Health Relevance Statement
Project Narrative
Ménière disease, characterized by adult fluctuating asymmetric hearing loss associated with attack of vertigo is
a debilitating disease for which the pathophysiology is still unknown. This collaborative effort aims to identify
genetics variants of Ménière disease patients and their relation to transcriptomic and epigenetic regulation of
the lateral wall. This project will allow us to gather preliminary data to investigate the pathogenesis of Ménière
disease at the molecular level.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AccelerationAdultAffectAll of Us Research ProgramAnimalsAtrophicAuditoryAwardBiological AssayBloodCandidate Disease GeneCell WallCellsChromatinCochleaCollaborationsComplexDataData SetDatabasesDefectDevelopmentDiagnosisDiseaseDistalEarElementsEndolymphEndolymphatic HydropsEnhancersEpigenetic ProcessEtiologyFacultyFoundationsFunctional disorderFundingFutureGenesGeneticGenetic TranscriptionGenetic VariationGoalsHealthHearingHomeostasisHot SpotHumanIndividualInfrastructureInvestigationKnowledgeLabyrinthLateralLeadLearningLigamentsLinkLiquid substanceMeniere's DiseaseModificationMolecularMusMutationParticipantPathogenesisPatientsPersonsPhasePrivatizationProductionQuality of lifeRegulationRegulatory ElementReporterResearchResourcesRicketsScienceStria VascularisTemporal bone structureTinnitusTissue BanksUnited StatesUnited States National Institutes of HealthUntranslated RNAValidationVariantVascularizationVertigoasymmetric hearing lossbasebiobankcandidate identificationcell typedata integrationepigenetic regulationexperienceexperimental studygenetic analysisgenetic architecturegenetic variantgenome sequencinggenome wide association studyhealth datahearing impairmenthistone modificationimprovedinner ear diseasesinsightmembranous labyrinthmouse modelprogressive hearing losspromotersingle-cell RNA sequencingsynergismtranscriptometranscriptomicstranslational scientistvestibular systemwhole genome
No Sub Projects information available for 3P20GM139762-04S2
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 3P20GM139762-04S2
Patents
No Patents information available for 3P20GM139762-04S2
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 3P20GM139762-04S2
Clinical Studies
No Clinical Studies information available for 3P20GM139762-04S2
News and More
Related News Releases
No news release information available for 3P20GM139762-04S2
History
No Historical information available for 3P20GM139762-04S2
Similar Projects
No Similar Projects information available for 3P20GM139762-04S2